期刊文献+

CD 44V6、β-catenin在骨肉瘤中的表达及其临床意义 被引量:3

Expressions of CD 44V6 and β-catenin in osteosarcoma and their clinical significance
下载PDF
导出
摘要 目的:检测CD44V6、β-catenin在骨肉瘤组织中的表达,分析其表达与人骨肉瘤细胞侵袭及转移能力的相关性。方法:应用免疫组织化学方法检测35例骨肉瘤、15例骨软骨瘤、15例正常骨组织中CD 44V6、β-catenin的表达。结果:骨肉瘤组织中CD 44V6、β-catenin的阳性表达显著高于骨软骨瘤及正常骨组织(P<0.01);两者的表达分别与骨肉瘤临床分期、肿瘤转移及2年内死亡有关(P<0.05),而与患者性别、年龄、肿瘤大小、病理分型、术前化疗无关(P>0.05);两者的阳性表达呈正相关(P<0.01)。结论:CD 44V6、β-catenin在骨肉瘤中的阳性表达与骨肉瘤的发生、发展和转移密切相关,可能在骨肉瘤细胞侵袭、转移的过程中起协同作用;联合检测CD 44V6、β-catenin可以作为骨肉瘤诊断及其转移预测的指标。 Objective:To detect the expressions of CD 44V6 and β-catenin in osteosarcoma and to analyze the association of their expressions with migration and invasion of osteosarcoma cells. Methods:Expressions of CD 44V6 and β-catenin were examined by immunohistochemical SP method in 35 specimens of human osteosarcoma tissues, 15 specimens with osteochondroma, and 15 cases of normal bone tissues. Results:The positive expressions of CD 44V6 and β-catenin were significantly higher in osteosarcoma than osteochondroma and normal control tissues (P〈0.01). Their expressions significantly correlated with clinical staging, tumor metastasis, and 2-year death (P〈0.05); but had no correlation with the age and gender of patients, tumor size, histological classification, and with or without preoperative chemotherapy (P〉0.05). In osteosarcoma, expression of CD 44V6 was positively associated with the expression of β-catenin (P〈0.01). Conclusion:The positive expressions of CD 44V6 and β-catenin closely correlate with the occurrence, development, and metastasis of osteosarcoma. They may play synergistic role in the invasion and metastasis of osteosarcoma. Combined detection of CD 44V6 and β-catenin may be used as an indicater for diagnosis and prognosis of metastasis of osteosarcoma.
出处 《肿瘤》 CAS CSCD 北大核心 2008年第2期136-138,共3页 Tumor
关键词 骨肉瘤 基因表达 抗原 CD44 Β-连环素 肿瘤侵袭 肿瘤转移 Osteosarcoma Gene expression Antigens,CD 44 Beta catenin Neoplasm invasiveness Neoplasm metastasis
  • 相关文献

参考文献9

  • 1郭全义,卢世璧,张莉,眭翔,田玥,许文静,孙明学.骨肉瘤的治疗及生存率的多因素分析[J].中国矫形外科杂志,2006,14(7):497-499. 被引量:13
  • 2BASSAROVA A V, TORLAKOVIC E, SEDLOEV T, et al. Simultaneous bilateral breast carcinoma: Histopathological characteristics and CD44/catenin-cadherin profile[ J]. Histol Histopathol, 2005, 20(3) : 791-799. 被引量:1
  • 3BENDARDAF R, ELZAGHEID A, LAMLUM H, et al. E-cadherin, CD44S and CD44V6 correlate with tumor differentiation in colorectal cancer[J]. Oncol Rep,2005,13 (5) :831-835. 被引量:1
  • 4HONG S C, SONG J Y, LEE J K, et al. Significance of CD44V6 expression in gynecologic malignancies[ J ]. J Obstet Gynaecol Res, 2006, 32(4) : 379-386. 被引量:1
  • 5辛榕,郭乔楠,冯俊明.粘附分子CD44、CD44V3、CD44V6及PCNA在人骨肉瘤中的表达及其临床意义[J].第三军医大学学报,2003,25(10):874-876. 被引量:11
  • 6张新宇,匡正达,杨传铎,史占军.骨肉瘤组织iNOS和CD44的表达及意义[J].中国矫形外科杂志,2005,13(7):532-534. 被引量:3
  • 7VOUTILAINEN K A, ANTTILA M A, SILLANPAA S M, et al. Prognostic significance of E-cadherin-catenin complex in epithelial ovarian cancer[J]. Clin Pathol, 2006, 59(5) : 460-467. 被引量:1
  • 8JULKUMAN K, MAKINEN K, KARJA V, et al. alpha-beta and chiβ-catenin expression in human pancreatic cancer [ J ]. Cancer Anticancer Res, 2003, 23 (6D): 5043-5047. 被引量:1
  • 9TAKAHASHI M, TSUNODA T, SEIKI M, et al. Identification of membrane type matrix metalloproteinase-I as a target of the β-catenin/TCF4 complex in human colorectal cancers [ J ]. Oncogene, 2002,21 (38) :5861-5867. 被引量:1

二级参考文献22

  • 1仲江波,高聿同,张伟,孙成良.人工假体置换在膝关节周围侵袭性骨肿瘤中的应用[J].中国矫形外科杂志,2005,13(3):195-197. 被引量:7
  • 2刘子君.骨与关节病理学[M].北京:人民卫生出版社,1994.149-151. 被引量:4
  • 3[7]Wielenga V J, Heider K H, Offerhaus G J, et al. Expression of CD44-variant proteins in human colorectal cancer is related to tumor progression[J]. Cancer Res, 1993,53:4754-4756. 被引量:1
  • 4[8]Kuryu M, Ozaki T, Nishida K, et al. Expression of CD44-variants in osteosarcoma[J]. J Cancer Res Clin Oncol, 1999,125(11):646-652. 被引量:1
  • 5Chinje EC, Williams KJ,Telfer BA, et al. 17 beta-Oestradiol treatment modulates nitric oxide synthase activity in MDA231 tumour with impli cations on growth and radiation response[ J]. J Cancer(Br) ,2002,86(1) :136 ~ 142. 被引量:1
  • 6Cobbs CS, Brenman JE, Aldape KD, et al. Expression of nitric oxide synthase in human central nervous system tumors [ J ]. Cancer-Res, 1995,55:727 ~ 730. 被引量:1
  • 7Hassan H. J. and Jane E. A. CD44 expression in fetal rat bone:in vivo and in vitro analysis[ J]. Experimental Cell Research, 1996,223:467 ~ 477. 被引量:1
  • 8Su W, Sin M, Darrow A,et al. Malignant peripheral nerve sheath tumor cell invasion is facilitated by Src and aberrant CD44 expression [ J ].Glia,2003,42(4) :350 ~ 358. 被引量:1
  • 9Bhatavdekar JM, Patel DD, Chikhlikar PR, et al. Overexpression of CD44:a useful independent predictor of prognosis in patients with colorectal carcinomas[ J ]. Surg-Oncol (Am) , 1998,5 ( 6 ) :495 ~ 501. 被引量:1
  • 10Ferrari S,Bortoni M,Morcuni M,et al.Predictive factors of disease free survival for non-metatastic osteosarcoma of the extremity:an analysis of 300 patients treated at the Rizzoli institute[J].Ann Oncol,2001,12:1145-1150. 被引量:1

共引文献22

同被引文献43

  • 1李文辉,赵炬才,皮国富.人骨肉瘤p16基因表达及临床意义[J].实用诊断与治疗杂志,2005,19(7):483-484. 被引量:5
  • 2易成腊,李新志,徐卫国,陈安民.Relationship between the Expression of MTA-1 Gene and the Metastasis and Invasion in Human Osteosarcoma[J].Journal of Huazhong University of Science and Technology(Medical Sciences),2005,25(4):445-447. 被引量:10
  • 3Lewis IJ, Nooij MA, Whelan J, et al. Improvement in histnlngie re- sponse but not survival in osteosarcoma patients treated with inten- sified chemotherapy: a randomized phase llI trial of the European Osteosarcoma Intergroup [ J ]. J Nail Cancer lnsl, 2007,99 ( 2 ) : 112 - 128. 被引量:1
  • 4Meyers PA, Sehwartz CL, Krailo MD, et al. Osteosarcoma : the addi- tion of muramyl tripeptideto chemotherapy improves overall survival a report from the Children's Oncnlogy Group [ J ]. J Clin Oneol, 2008,26(4) :633 -638. 被引量:1
  • 5Bielaek SS, Kempf - Bielaek B, Delling G, eL al. Prognostic factors in high - grade osteosarcoma of the extremities or trunk:an analysis of 1702 patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols[J]. J Clin Oncol,2002,20 ( 3 ) :776 - 790. 被引量:1
  • 6Verma UN, Surabhi RM, Schmaltieg A, et al. Small interfering RNAs directed against beta -catenin inhibit the in ~itro and in vivo growth of colon cancer ceils [ J ]. Clin Cancer Res, 2003,9 (4) :1291 - 1300. 被引量:1
  • 7C ui J, Jiang W, Wang S, et al. Role of Wnt/13 - catenin signaling in drug resistance of pancreatic cancer [ J 1. Curr Pharm Des, 2012,18(17) :2464 -2471. 被引量:1
  • 8Chen K, Fallen S, Abaan HO, et al. Wntl0b induces chemo - taxis of osteosarcoma and correlates with reduced survival [ J ]. Pediatr Blood Cancer,2008,51 (3) :349 - 355. 被引量:1
  • 9Guo Y,Zi X, Koontz Z, et al. Blocking Wnt/LRP5 signaling by a soluble receptor modulates the epithelial to mesenehymal transition and suppresses met and metalloproteinases in osteosarcoma Saos - 2 cells[ J]. J Orthop Res,2007,25 (7) :964 - 971. 被引量:1
  • 10Hoang BH, Kubo T, Healey JH, et al. Diekkopf 3 inhibits invasionand motility of Saos -2 osteosarcoma cells by modulating the Wnt - beta - catenin pathway [ J ]. Cancer Res, 2004,64 ( 8 ) : 2734 - 2739. 被引量:1

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部